Archive: 21/03/2016

Review and view of future in cancer in adolescents, young adults

A narrative review published online by JAMA Pediatrics examines the current status of cancer in adolescents and young adults and offers a view of the future.

Mar 21, 2016

Bevacizumab use in preemies associated with disabilities

(HealthDay)—Bevacizumab (Avastin) used to treat retinopathy of prematurity (ROP) may be linked to serious disabilities such as cerebral palsy and hearing loss, according to a study published online March 17 in Pediatrics.

Mar 21, 2016

0

6

More elderly using dangerous drug combinations

One in six older adults now regularly use potentially deadly combinations of prescription and over-the-counter medications and dietary supplements—a two-fold increase over a five-year period, according to new research at ...

Mar 21, 2016

0

5

Gene tests may help predict outcomes in advanced ovarian cancer

(HealthDay)—A special genetic test might help gauge outcomes for women diagnosed with ovarian cancer, a new study suggests.

Mar 21, 2016

0

47

Propranolol for hemangiomas doesn't impair infant growth

(HealthDay)—For infantile hemangiomas, systemic propranolol appears safe and does not impair physical growth, according to a study published online March 6 in the Journal of Dermatology.

Mar 21, 2016

0

2

FDA approves new injection to combat anthrax

Federal health officials have approved a new injectable drug to treat patients who have been exposed to the deadly toxin anthrax.

Mar 21, 2016

Social media beneficial for sharing and building upon patient experiences, research shows

Twitter, Facebook and other social media platforms can be useful tools for helping patients with rare medical diseases exchange knowledge and build communities, research from the University of Leicester has found.

Mar 21, 2016